Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

The use of oral anticoagulants (warfarin) in older people. American Geriatrics Society guideline.

American Geriatrics Society Clinical Practice Committee.

J Am Geriatr Soc. 2002 Aug;50(8):1439-45; discussion 1446-7. No abstract available.

PMID:
12165003
2.

The use of oral anticoagulants (warfarin) in older people. AGS Clinical Practices Committee. American Geriatric Society.

[No authors listed]

J Am Geriatr Soc. 2000 Feb;48(2):224-7. No abstract available.

PMID:
10682955
3.
5.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Selçuk H, Selçuk MT, Maden O.

Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8. Review. Turkish.

6.

Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.

Lane DA, Lip GY.

Thromb Haemost. 2009 May;101(5):802-5. No abstract available. Erratum in: Thromb Haemost.2010 Sep;104(3):653.

PMID:
19404530
7.

The need for new oral anticoagulants in clinical practice.

Hylek EM.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. doi: 10.2459/JCM.0b013e32832e4954. Review.

PMID:
19571764
8.

Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.

Torn M, Cannegieter SC, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.

Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176.

PMID:
19597069
9.

Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin.

Roberts N, Ross D, Flint SK, Arya R, Blott M.

BJOG. 2001 Mar;108(3):327-9. No abstract available.

11.

The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.

Singer DE, Fang MC, Go AS.

Arch Intern Med. 2009 Nov 23;169(21):2032; author reply 2033. doi: 10.1001/archinternmed.2009.419. No abstract available.

PMID:
19933969
13.

Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.

Samama CM, Vray M, Barré J, Fiessinger JN, Rosencher N, Lecompte T, Potron G, Basile J, Hull R, Desmichels D; SACRE Study Investigators.

Arch Intern Med. 2002 Oct 28;162(19):2191-6.

PMID:
12390061
14.

The impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study.

Parkash R, Wee V, Gardner MJ, Cox JL, Thompson K, Brownell B, Anderson DR.

Can J Cardiol. 2007 May 1;23(6):457-61.

15.

Oral anticoagulation and mechanical heart valves: the case of the elderly and pregnancy.

Rubboli A, Di Pasquale G.

Ital Heart J. 2005 May;6(5):405-8. No abstract available.

PMID:
15934414
16.

Atrial fibrillation and stroke prevention.

Hart RG.

N Engl J Med. 2003 Sep 11;349(11):1015-6. No abstract available.

PMID:
12968083
17.

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

Hirsh J, Fuster V.

Circulation. 1994 Mar;89(3):1469-80. No abstract available. Erratum in: Circulation 1995 Jan 15;91(2):A55-A56.

PMID:
8124830
18.
19.

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Själander A, Wallentin L, Rosenqvist M, Svensson P.

Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Swedish. No abstract available.

PMID:
19006862
20.

Supplemental Content

Support Center